Clinical Trials Logo

Clinical Trial Summary

This observational study is specifically designed to identify the pre-operative risk factors that significantly contribute to perioperative packed red cell transfusions in open liver resection procedures. The main question it aims to answer are: 1. What are the risk factors of peri-operative blood transfusion in open liver resection procedures 2. What are the difference outcomes between patients who receive blood transfusion and the other group. Researcher will compare perioperative factor and post operative outcomes between transfused and non-transfused group


Clinical Trial Description

After approval of the study protocol from the institutional review board of Chiangmai University (Approval number: ANE-2564-08020), we performed a retrospective review of all patients who underwent an elective open liver resection in our specialized hepato-biliary center from January 2006 through December 2017. This retrospective inquiry comprised 808 patients. The data was systematically retrieved from electronic medical records. Baseline characteristics including age, gender, body mass index (BMI), co-morbidity, American Society of Anesthesiologists (ASA) classification, diagnosis, hepatitis profile, Child-Pugh classification, cirrhosis, the largest tumor size, previous liver resection, and pre-operative laboratory investigations were collected. The following intra-operative data were collected: type of liver resection, hilar resection, vascular reconstruction, volume and type of fluid administration, estimated blood loss, packed red cell and blood product transfusion, and operation time. The definitions of liver resection and the type of hepatectomy were aligned with the anatomic classification of the Brisbane 2000 Terminology ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06189911
Study type Observational
Source Chiang Mai University
Contact
Status Completed
Phase
Start date January 1, 2006
Completion date January 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05077124 - Safe and Timely Antithrombotic Removal (STAR) Registry
Completed NCT03622671 - Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting N/A
Not yet recruiting NCT06060327 - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section N/A
Completed NCT02509312 - Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery Phase 4
Recruiting NCT05316649 - Blood Loss Quantification During Major Abdominal Surgery
Completed NCT03967171 - The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery N/A
Completed NCT05273632 - Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline) N/A
Completed NCT05204056 - Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty N/A
Active, not recruiting NCT03805607 - IV Ketorolac on Platelet Function Post-Cesarean Delivery Phase 4
Completed NCT03249038 - Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss. N/A
Terminated NCT05093504 - Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D) N/A
Recruiting NCT06049160 - Comparative Study Between Preoperative and Postoperative Rectal Misoprostol N/A
Completed NCT04976530 - Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) N/A
Completed NCT03555383 - Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)
Active, not recruiting NCT02438566 - Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery Phase 3
Completed NCT04656067 - Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate Phase 1/Phase 2